Clinical Trial to Evaluate BO-112 in Patients With Basal Cell Carcinoma (BCC)

Clinical trial NCT06422936 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT06422936
Sponsor: Highlight Therapeutics
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Basal Cell Carcinoma

Start date: 2024-05-27
Primary completion: 2026-06-01
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.